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Abstract
Tau protein is present in six different splice forms in the human brain and interacts with microtubules
via either 3 or 4 microtubule binding repeats. An increased ratio of 3 repeat to 4 repeat isoforms is
associated with neurodegeneration in inherited forms of frontotemporal dementia. Tau
overexpression diminishes axonal transport in several systems, but differential effects of 3 repeat
and 4 repeat isoforms have not been studied. We examined the effects of tau on mitochondrial
transport and found that both 3 repeat and 4 repeat tau change normal mitochondrial distribution
within the cell body and reduce mitochondrial localization to axons; 4 repeat tau has a greater effect
than 3 repeat tau. Further, we observed that the 3 repeat and 4 repeat tau cause different alterations
in retrograde and anterograde transport dynamics with 3 repeat tau having a slightly stronger effect
on axon transport dynamics. Our results indicate that tau-induced changes in axonal transport may
be an underlying theme in neurodegenerative diseases associated with isoform specific changes in
tau’s interaction with microtubules.
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In the adult human brain, there are six isoforms of the tau gene expressed, with an
approximately 50/50 ratio of isoforms containing either 3 microtubule binding repeats (not
including exon 10) or 4 microtubule binding repeats (including exon 10) (Goedert et al.
1989; Kosik et al. 1989; Goedert and Jakes 1990). Although it has been postulated that the 4
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repeat isoforms bind microtubules more avidly than the 3 repeat isoforms (Butner and
Kirschner 1991), a direct comparison of the 3 repeat and 4 repeat isoforms on microtubule
function has not been reported. The issue is of importance from a pathophysiologic perspective,
because the ratio of 3 repeat to 4 repeat tau is substantially altered in many cases of autosomal
dominantly inherited frontotemporal dementia, in which changes in splice acceptor domains
stabilize the 4 repeat form of the molecule (Hutton 2000; Hasegawa 2006; Tsuboi 2006). A
striking increase in 4 repeat to 3 repeat ratio is observed in sporadic corticobasal ganglionic
degeneration and progressive supranuclear palsy as well as frontotemporal dementia (Ingelsson
et al. 2007). In Alzheimer’s disease, a subtle increase in 4 repeat tau has also been detected
(Conrad et al. 2007).
Microtubule-dependent transport of mitochondria into the axon is a critical factor to maintain
local ATP generation in distal compartments in neurons. Although true in all cells, neurons
place an especially heavy burden on microtubule-dependent transport processes by motor
proteins because of the extraordinary distances involved in these highly polarized cells. In
previous studies, utilizing Chinese hamster ovary (CHO) cells (Ebneth et al. 1998), N2A cells
(Mandelkow et al. 2004) cultured retinal ganglion cells (Mandelkow et al. 2004), or NB2a/d1
cells (Dubey et al. 2008), overexpression of full-length tau led to a consistent phenotype of
diminished anterograde transport of a variety of kinesin cargos, including organelles. For
example, mitochondria were noted to accumulate within the cell body, and to cluster near the
microtubule organizing center (Ebneth et al. 1998). These studies suggested that tau competes
for kinesin-mediated anterograde transport when it is bound to microtubules. In support of this
model, the velocity of microtubule-dependent transport of vesicles and organelles was not
observed to change, but the likelihood that organelles attach to microtubules was altered by
overexpression of full-length tau (Trinczek et al. 1999).
Thies and Mandelkow (2007) have recently demonstrated that co-expression of the kinase
microtubule associated protein/microtubule affinity-regulating kinase 2 (MARK2) can
partially rescue the tau over-expression phenotype, likely because MARK2 phosphorylates tau
near the microtubule binding domain repeats, removing tau from the microtubule tracks. These
results also suggest that tau binding to microtubules is critical to impair transport of
mitochondria, and that manipulations that alter tau binding to microtubules may therefore
impact this phenotype (Thies and Mandelkow 2007).
As 3 repeat tau is believed to be less tightly associated with microtubules than 4 repeat tau
(Hasegawa 2006; Tsuboi 2006), we postulated that 4 repeat tau may lead to greater alterations
of organelle transport than 3 repeat tau and, via for example loss of mitochondria from axons,
may pre-dispose to neurodegeneration. In this study, we therefore directly examined the effects
of over-expression of 3 repeat compared with 4 repeat tau on mitochondrial transport from cell
bodies into processes, and found that 4 repeat tau has a greater impact on mitochondrial
transport into axons than 3 repeat tau.
We also reasoned that we may be able to detect subtle changes in anterograde or retrograde
movement over several hundred microns of axons in comparison with earlier studies which
focused primarily on cultured cells with relatively short processes. To facilitate these studies,
we adapted for our use a novel nanochamber microfluidic device (made in house) that allows
culturing of primary neurons in one chamber, and the outgrowth of their axons into straight
channels that are ~1000 μm long. Using these devices, we were able to readily monitor
mitochondrial trafficking in axons. We find that tau over-expression leads to changes in
anterograde and retrograde transport, and that both isoforms impair transport, although the
specific effects of 3 repeat and 4 repeat tau differ.
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Materials and methods
Cloning
To create cyan fluorescent protein (CFP)-labeled tau proteins, subcloning of tau constructs of
different isoforms was carried out by standard PCR and ligation procedures. Tau3 repeat minus
2 minus 3 (excluding exons 2, 3, and 10), Tau3 repeat plus 2 plus 3 (including exons 2 and 3,
excluding 10), Tau4 repeat minus 2 minus 3 (excluding exons 2 and 3, including 10), and Tau4
repeat plus 2 plus 3 (including exons 2, 3, and 10) in PCDNA 3.1 were generously provided
by Dr. Mike Hutton (Mayo Clinic, Jacksonville, FL, USA). The tau gene from each construct
was obtained utilizing PCR (N-terminal primer 5′-
CTCGAGATGGCTGAGCCCCGCCAGGAGTTCGAAG-3′), containing an Xho-1 digestion
site and (C-terminal primer 5′-
AATAGGATCCAAACCCTGCTTGGCCAGGGAGGCAGAC-3′) with a BamH1 digestion
site. PCR products were digested with Xho-1 and BamH1 and ligated into double-digested
eCFP-N1 vector (Clontech, Mountain View, CA, USA).
For TauC3 construct, the longest human isoform of tau (4 repeat tau including exons 2 and 3)
was used to PCR the tau gene minus the last 60 bp (N-terminal primer 5′-
TGCACCTCGAGACATGGCTGAGCCCCGCCAGG
AGTTCGAAGTGCACCTCGAGACATGGCTGAGCCCCGCCAGGAGTTCGAAG-3′ and
C-terminal primer 5′-TTGGATCCCTAGTCTACCATGTCGATGCTGCCG-3′). Tau PCR
product was then digested, along with the pMAX-green fluorescent protein (GFP) vector
(Amaxa, Walkersville, MD, USA) and ligated into the digested vector. All vectors and
constructs were verified by sequence analysis.
Cell culture
H4 human neuroglioma cells were maintained in Opti-MEM (Gibco, Carlsbad CA, USA)
supplemented with 10% (v/v) fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL
streptomycin (Gibco). Cells were transiently transfected with the identified constructs using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
protocol.
Primary cortical neurons were prepared from cerebral cortices of mouse embryos (day 15–17
of gestation). Cortices were dissociated by trypsinization for 5 min at 23°C and cells were
resuspended in Neurobasal (NB) (Gibco) medium supplemented with 10% fetal bovine serum,
2 mM/L Gln, 100 U/mL penicillin, and 100 μg/mL streptomycin and centrifuged at 100 g for
10 min and resuspended in NB/B-27 [NB medium containing 2% (v/v) B-27 supplement], 100
U/mL penicillin, 100 μg/mL streptomycin, and 2 mM/L glutamine and plated at 1 × 106 on 42
mm round coverslips (Hemogenix, Colorado Springs, CO, USA), coated with Poly-D-Lysine
(20 μg/ml) (Sigma, St. Louis, MO, USA) in 60 mm cell culture dishes (Corning, Corning, NY,
USA) or in microfluidic devices as described later. Neurons were grown for 6–7 days in
vitro (DIV) and transiently transfected with the indicated constructs utilizing Lipofectamine
2000 (Invitrogen) according to the manufacturer’s protocol.
We examined whether tau over-expression altered the actin cytoskeleton by culturing cortical
neurons on poly-D-lysine-coated four-well chamber slides and differentiating neurons for 6–7
DIV. After differentiation, neurons were transfect as before, with either 3 repeat or 4 repeat
CFP-tau (both containing exons 2 and 3). Cells were then fixed, 24 h post-transfection with
4% paraformaldehyde for 1 h at 23°C, washed three times with phosphate-buffered saline
(PBS) and permeabilized with 0.5% Triton-X100 in PBS for 10 min at 23°C and washed in
PBS. CFP-Tau transfected neurons were fixed as before and neurons were then stained with
rhodamineconjugated phalloidin and washed three times with PBS. Slides were then mounted
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with Permount mounting media and allowed to dry, prior to visualization via confocal
microscopy. No qualitative difference in the actin staining was observed in tau-transfected
neurons.
To examine the extent to which tau transfection led to tau over-expression, neurons were
transfected, fixed, and prepared as before, then incubated with the Tau5 monoclonal antibody
at a dilution of 1/100 at 4°C overnight and washed thoroughly with PBS. The Tau5 primary
antibody was then labeled with an Alex 594 donkey antimouse secondary antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) at a dilution of 1/100 at 23°C for 1 h,
washed three times with PBS and mounted. Slides were then mounted with Permount mounting
media and allowed to dry, prior to visualization via confocal microscopy. Tau5 immunostaining
intensity was measured along a 10-μm-line drawn across the cell body, outside the nucleus
(line scan) for 10 transfected and 10 untransfected cells (see supporting information Fig. S1).
Mouse work was approved by the Massachusetts General Hospital Subcommittee on Research
Animal Care and conformed to National Institutes of Health (US) guidelines.
Western blotting
Cells were collected 48 h post-transfection in 100 μL 2× sodium dodecyl sulfate (SDS) lysis
buffer (0.25 M Tris–Cl, pH 7.5, 2% SDS, 5 mM EDTA, 5 mM EGTA, 10% glycerol
supplemented with a protease inhibitor pellet (Gibco). Cell lysates were then sonicated for 10
s and boiled for 10 min. Samples were then centrifuged at 23°C for 10 min at 15 000 g. Sample
concentrations were determined using the bicinchoninic acid assay (Pierce, Rockford, IL,
USA). Samples were diluted to 1 μg/μLin 2× SDS running buffer and loaded onto precast 4–
12% Tris–Glycine gradient polyacrylamide gels (Invitrogen), electrophoresed and transferred
to polyvinylidene difluoride membranes. Membranes were blocked for 1 h at 23°C in TBST
(20 mM Tris–Cl pH 7.6, 137 mM NaCl, 0.05% Tween 20) and 5% milk and incubated in TBST
and milk at 4°C overnight in indicated primary antibody. Membranes were then washed three
times for 10 min in TBST at 23°C and incubated for 1 h with appropriate horseradish
peroxidase-conjugated secondary antibody in TBST and milk. Membranes were washed three
times for 10 min in TBST at 23°C and visualized with enhanced chemiluminescence
(Amersham, Piscataway, NJ, USA).
Nano chamber devices
Microfluidic devices were adapted from Taylor et al. (2005) and manufactured in-house. The
device contains two chambers which are connected by 300 or 1000 μm channels that are 3
μm high and 8 μm wide. Initial experiments used 300 μm channels, but we found that 1000
μm channels were more convenient as they allowed visualization of a longer section of axon.
The device is attached to a poly-D-lysine coated coverslip, to which the cells adhere. This allows
the growth of axons through the channels and ensures that only one or two axons propagate
through each channel. Taylor et al. (2005) demonstrated that only axons propagate through the
channel for longer than 150 μm and that axons will consistently grow from one major chamber
to the other, with one chamber containing only cell bodies and the other containing axon
terminals and growth cones.
The microfluidic devices were loaded with mouse primary cortical neurons isolated from E15
mouse embryos that were trypsinized and dissociated and placed in the chamber at an
approximate density of 1 × 105 cells per device. Cells were transfected with the above tau
constructs on 6 or 7 DIV. One tau construct was transfected per device.
Transfections were carried out as follows: 1.2 μg of total DNA was used per device. 0.6 μg of
mitochondrial DsRed (Mito-DsRed) was used and 0.6 μg of Tau DNA was used per device.
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Neurons were transfected with Lipofectamine 2000 (Invitrogen) according to manufacturer’s
protocol. The only change made was that the cells were transfected in Dulbecco’s modified
Eagle’s medium, which was left on neurons for 2 h and then medium was changed back to
Neurobasal with B-27 supplement. Cells were left for 24 h and imaged the next day. Neurons
transfected with CFP-3R tau or CFP-4R tau were examined 24 h after transfection and the
amount of CFP signal, quantitated on a Zeiss 510 inverted microscope (Carl Zeiss, Jena,
Germany), was equal, suggesting that 3 repeat tau and 4 repeat tau were equally well translated
and equally stable under these conditions.
Coverslips containing the microfluidic device were examined using a Zeiss Axiovert 200
inverted microscope (Carl Zeiss) encased in a 37°C, 5% CO2 environmental chamber equipped
with a Zeiss LSM 510 META (Zeiss, Jena, Germany) confocal scanhead using 488 and 543
nm lasers and a Coherent (Santa Clara, CA, USA) Chameleon Ti/Saph at 800 nm ~140 fs pulse
width at 90 MHz, ~20–30 mW average power with linear polarization at the sample, for CFP
and GFP imaging. All images were acquired using a Zeiss 63× 1.2 NA C-APo-Plan NEOFLU
water immersion lens (Carl Zeiss), mounted on the microscope described before.
Calculation of mitochondrial distribution and clustering
H4 cells and primary neurons were co-transfected with GFP or one of the GFP or CFP-tau
constructs (Fig. 1) and Mito-DsRed to label mitochondria. Images of cell bodies and, in the
case of cultured neurons, axons, were acquired using a Zeiss 63× 1.2 NA C-APo-Plan NEOFLU
water immersion lens, mounted on the microscope described before (n = 45 H4 cells and 35
neurons per transfection condition). In Image J (free software from the National Institutes of
Health, Bethesda, MD, USA), the green (for GFP) or blue (for CFP constructs) and red channels
were thresholded separately (to the edge of the intensity histogram). The cell body was outlined
in the GFP or CFP channel and the analyzed particles’ function was used on the red channel
to find the percentage area occupied by mitochondria. A decrease in the percentage of
cytoplasm occupied by mitochondria is interpreted to mean the mitochondria are clustering
near the nucleus instead of being transported to the cell periphery.
Generation of kymographs and calculation of mitochondrial dynamics
Kymographs were obtained from time series images obtained on the Zeiss LSM 510 META.
Images were acquired every 2 s and 100 images were acquired for a total of 200 s. Movies
were then input into Metamorph and kymographs were generated using the kymograph
function of the software, based on tracing a line along the length of travel of a mitochondrion
along an axon by hand. Kymographs were then analyzed using a specialized macro created in
Matlab (Mathworks, El Segundo, CA, USA) that calculated the velocity in the anterograde and
retrograde directions. The macro also calculated the percentage of time traveled in the antero-
and retrograde directions per mitochondrion. In each condition, at least 35 mitochondria were
imaged, from at least 10 individual neurons from at least three separate neuron preparations.
Each condition was pooled and analyzed as described next. As a result of the low transfection
efficiency (typically 1–2% in differentiated neurons), the incidence of transfected axons
spanning the microfluidic nanochannel is relatively low. Therefore, only a few axons per device
are able to be utilized to analyze mitochondrial behavior.
Statistics
Normality of data was assessed using a Shapiro–Wilks test. As datasets were not normally
distributed, non-parametric analyses were used. For two group comparisons, Mann–Whitney
tests were used (control vs. tau and 3 repeat vs. 4 repeat) and for multiple group comparisons
(tau isoforms), Kruskal–Wallis tests were used. Data are presented as box plots, which display
the median value (line inside the box), upper quartile (top of the box), lower quartile (bottom
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of the box), 90th percentile (top whisker), 10th percentile (bottom whisker), and all values
below the 10th and above the 90th percentile (potential outliers) shown as dots.
Results
Previous studies have clearly demonstrated that over-expression of full-length tau leads to the
clustering of organelles in the cell (Ebneth et al. 1998; Trinczek et al. 1999; Seitz et al.
2002; Stamer et al. 2002; Thies and Mandelkow 2007; Dixit et al. 2008; Dubey et al. 2008;
Ittner et al. 2008). The percentage of cytoplasmic area in which mitochondria are located is
substantially changed by over-expression of tau. For example, in CHO cells, the percent of
cellular area populated by mitochondria is more than 50%, and this diminishes to below 20%
in the presence of over-expressed full-length tau (Mandelkow et al. 2004). We utilized this
same mitochondrial clustering assay to initially examine the effects of different isoforms of
tau (Fig. 1), including the two major human isoforms: the shortest isoform containing 3
microtubule binding domain repeats and missing the two small amino terminal exons 2 and 3
(3 repeat tau minus 2 minus 3) and full-length 4 repeat tau which includes exons 2, 3 and 10.
We also examined the effects of other isoforms (e.g., 4 repeat minus exon 2 and exon 3; 3
repeat minus exon 2 and exon 3) as well as a carboxy terminal truncation at position 421,
mimicking a postulated caspase cleavage product of tau (Krishnamurthy et al. 2000). These
constructs therefore provide physiologically relevant alterations of the amino terminal domain
(exons 2 and 3), the microtubule binding domain (exon 10, 3 repeat vs. 4 repeat), and the
carboxy terminal domain (truncation at position 421). We first utilized human H4 neuroglioma
cells, which, like CHO cells, are relatively easy to transfect and have a flat, easy to image
cytoplasm. The CFP-Tau constructs along with the Mito-DsRed construct were co-transfected
into H4 cells. As expected, tau over-expression markedly decreased the overall area occupied
by mitochondria (Fig. 2a). Separate transiently transfected H4 cells were collected and western
blotted to verify construct expression and protein properties. Expression was similar in all
conditions and all constructs migrated as expected on SDS–Polyacrylamide gel
electrophoresis, indicating that the tau constructs express and produce the expected tau isoform.
Tau over-expression led to a clear phenotype of clustering of the mitochondria within the cell
body 24 h after transfection causing a 50% decrease in the area of the cell body occupied by
mitochondria (Mann–Whitney test p < 0.0001) (Fig. 2b). Although all tau isoforms had a
statistically significant effect on mitochondrial transport to the cell periphery, interestingly all
constructs containing 4 microtubule binding repeats had a more profound effect than constructs
containing only 3 repeats (Mann–Whitney test 3 repeat vs. 4 repeat split by presence of tau;
tau group p < 0.0001). Manipulation of the amino terminal exons 2 and 3, or deletion of the
carboxyl terminal 20 amino acids to mimic caspase cleavage, did not further impact the tau-
induced change in mitochondrial localization in H4 cells (Fig. 2b). Experiments using untagged
Tau constructs cotransfected with Mito-DsRed showed similar results (data not shown),
indicating that the presence of the CFP or GFP tag on tau constructs did not contribute to the
mitochondrial clustering phenotype. Tau over-expression in these experiments was verified by
immunocytochemistry following the fixation of the cells.
To further evaluate the effects of the 3 repeat and 4 repeat tau constructs in neurons, we utilized
a new microfluidic nanochamber device. This device has a reservoir for neuronal cell bodies,
a series of rather long, thin channels that are only 3 μm high, 8 μm wide, and either 300 or
1000 μm long that contain axons, and a second reservoir chamber which contains only axon
terminals. The design for these chambers was adapted from Taylor et al. (2005) (Fig. 3a).
Neurons were grown in the reservoir and, as expected, axons grew down the channels over the
course of the first week in culture. Each channel is wide enough to accommodate only a few
axons at a time, and staining of neurons on a device with Mitotracker Green, reveals some
channels with multiple axons (typically two or three), and a majority with only one axon
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present. This is not an issue in the experiments described below, as the likelihood of two cells
being transfected and sending axons through the same channel is minimal, and CFP signal
showed only a single transfected axon in each channel examined (Fig. 3b). Neurons were co-
transfected with CFP-Tau and Mito-DsRed, allowing observation of the percentage of cell
soma occupied by mitochondria, the density of mitochondria in axons, and (via generation of
time-lapse confocal optical section stacks) data on mitochondrial transport, direction and
velocities.
To determine relative levels of expression of 3 repeat and 4 repeat tau in neurons, we transfected
neurons with 3 repeat or 4 repeat tau tagged with CFP and quantified the intensity of CFP
fluorescence in processes from 10 cells per condition by immunostaining with an anti-tau
antibody. We found that intensity of 3 repeat and 4 repeat tau stains do not differ, indicating
similar expression levels of 3 repeat and 4 repeat tau with transfection. Measurement of both
endogenous and expressed CFP-tagged tau, showed that both 3 repeat and 4 repeat exogenous
tau are expressed at ~1.6-fold, the level of the endogenous tau (see supporting information Fig.
S1).
To examine whether tau over-expression alters the normal actin filaments in transfected cells,
differentiated neurons were transfected with either the 3 repeat or 4 repeat CFP-tau and stained
with rhodamine phalloidin. No difference was observed between the CFP-tau transfected and
untransfected neurons.
We next examined the percentage of the neuronal cell body occupied by mitochondria as a
function of tau transfection (Fig. 4a). Again, a marked and highly statistically significant effect
of tau on mitochondrial clustering in the cell body was observed (p < 0.0001, Mann–Whitney
test control vs. tau). Although both 3 repeat-containing isoforms and 4 repeat-containing
isoforms had a strong and statistically significant effect on mitochondrial clustering, there was
a clear isoform difference in which 4 repeat forms had a stronger effect on mitochondrial
localization than 3 repeat forms (p < 0.0001, Mann–Whitney test 3 repeat vs. 4 repeat, tau
group). Within the 3 repeat isoforms, the inclusion or exclusion of the N-terminal exons 2 and
3 had no further effect on mitochondrial distribution (p > 0.05, post hoc Mann–Whitney test
3 repeat minus 2 minus 3 vs. 3 repeat plus 2 plus 3). However, 4 repeat tau without exons 2
and 3 (4 repeat minus 2 minus 3) had less effect on mitochondrial distribution than the longer
4 repeat plus 2 plus 3 or 4 repeat C3 isoforms (p < 0.0001, post hoc Kruskal–Wallis test on 4
repeat isoforms, p < 0.0001 post hoc Mann–Whitney tests comparing 4 repeat minus 2 minus
3 to 4 repeat plus 2 plus 3 and p < 0.0001 post hoc Mann–Whitney test comparing 4 repeat
minus 2 minus 3 to 4 repeatC3). Overall, these data show substantial similarities in the effect
of tau isoforms on mitochondrial translocation to the periphery of the cell between H4 cells
and neurons, and suggest that the number of microtubule binding repeats influences this
process.
To examine whether the increased clustering of mitochondria in the neuronal cell body was
associated with impaired trafficking of mitochondria to axons, we measured the density of
mitochondria in axons. As expected, tau transfection led to a significant reduction in the area
of mitochondria in axons (p < 0.0001, Mann–Whitney test control vs. tau), and this effect was
more pronounced for 4 repeat compared with 3 repeat tau (p < 0.0001 post hoc Mann–Whitney
test 3 repeat vs. 4 repeat, tau group only). The area of mitochondria per axon examined was
reduced by about 33% by 4 repeat tau over-expression, and by about 20% by 3 repeat tau
overexpression (Fig. 4b).
This result suggests that mitochondria are less likely to reach axons and engage the axonal
microtubular tracks in the presence of tau. To examine whether the mitochondria that do engage
axonal microtubular tracks then move normally, or if tau also alters trafficking of mitochondria
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in axons, we measured the kinetics of mitochondrial trafficking in axons using microfluidic
channels. Several technical difficulties confound measurement of organelle transport in axons
in primary neurons in culture. In routinely used 35 mm dishes, it is often somewhat difficult
to distinguish axons from dendrites without immunostaining which, of course, precludes live-
cell imaging. Processes tend to cross each other innumerable times, making it difficult to
observe a long expanse of a relatively straight process. We utilized microfluidic devices to
overcome these issues. The configuration of the channels precludes short dendritic processes
from growing down the channel (Taylor et al. 2005).
We constructed our chambers to be 300 or 1000 μm in length, allowing relatively long, straight
expanses of each axon to be imaged (Fig. 3). Mouse primary neurons were cultured for 6–7
days in the device, followed by the transfection of the neurons with either CFP or CFP-Tau
along with Mito-DsRed. The axons were imaged in an environmental chamber which enclosed
the entire microscope, holding temperature at 37°C with 5% CO2 and optimal humidity for
long-term experiments. We found that, under these conditions, we could monitor both
anterograde and retrograde movement and calculate velocity. From these transfected cells,
time-lapse movies were made and kymographs generated (Fig. 5a). Transfecting CFP alone,
average mitochondrial anterograde velocity was 0.24 μm/s, and retrograde velocity was 0.22
μm/s, which is in agreement with recent data by Gerencser and Nicholls (2008). Transfection
with either 3 repeat or 4 repeat tau slowed average velocity (both anterograde and retrograde
averaged together: transfected axons, p < 0.0001 Mann–Whitney test control vs. tau). The
effect on anterograde velocity was larger than the effect on retrograde velocity (significant
reduction of anterograde velocity with tau over-expression, p = 0.03 Mann–Whitney test; no
significant effect on retrograde velocity p = 0.08 Mann–Whitney test), leading to a net decrease
in the anterograde to retrograde ratio. Surprisingly, the effect on anterograde velocity was more
pronounced with 3 repeat tau than 4 repeat tau (p < 0.0001 post hoc Mann–Whitney test 3
repeat vs. 4 repeat, tau group). Thus, 3 repeat tau slow down motors to a greater extent than 4
repeat tau, although both decrease the anterograde velocity ratios leading to a bias against plus-
end directed transport.
In CFP-transfected neurons, 33% (median) of mitochondria move in the anterograde direction
and 16% move in the retrograde direction, while in tau-transfected neurons 17% of
mitochondria move in the anterograde direction and 49% in the retrograde direction, a
significant decrease and increase, respectively (p < 0.0001 Mann–Whitney test control vs. tau
for both percent anterograde moving and percent retrograde moving). These values are medians
from at least 35 neurons analyzed over three preparations per conditions. As illustrated in the
kymograph in Fig. 5a, there are numerous mitochondria that do not move appreciably in the
time course observed, thus the percent mitochondria moving in either direction do not add up
to 100%. These changes indicate an imbalance in transport which likely contributes to the
accumulation of mitochondria in the cell body. There is no difference between 3 repeat and 4
repeat isoforms on percent anterogradely moving mitochondria, but 3 repeat tau has a more
pronounced effect on increasing the percent retrogradely moving mitochondria (p < 0.0001,
post hoc Mann–Whitney test 3 repeat vs. 4 repeat, tau group). The shortest isoform, 3 repeat
minus 2 minus 3 has a more pronounced effect than 3 repeat plus 2 plus 3 (p = 0.003, post hoc
Mann–Whitney test). Within the 4 repeat group, the 4 repeat minus 2 minus 3 isoform has more
of an effect than either of the longer 4 repeat isoforms used (p = 0.001 for 4 repeat minus 2
minus 3 vs. 4 repeatC3; and p < 0.0001 for 4 repeat minus 2 minus 3 vs. 4 repeat plus 2 plus
3, post hoc Mann–Whitney tests), indicating a more pronounced effect on the percent
retrogradely moving mitochondria without the two N-terminal inserts. The total percentage of
mitochondria moving in either direction is decreased by tau over-expression from 21.4% to
13.3% (median, p = 0.001, Mann–Whitney test tau vs. control), with no difference between 3
repeat and 4 repeat tau (p > 0.05, post hoc Mann–Whitney test 3 repeat vs. 4 repeat tau group).
Thus, the amino terminal domain of tau may impact this aspect of organelle trafficking.
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Together, these data indicate that tau leads to a decrease in mitochondria translocating to the
axon, a decrease in the percentage of mitochondria moving in the axon, a pronounced shift in
the balance of anterograde to retrograde transport with fewer mitochondria moving away from
the cell body and more moving toward it (Mandelkow et al. 2003), and a decrease in the velocity
of mitochondria, with a more pronounced effect on slowing mitochondria moving away from
the cell body while allowing normal speed of transport toward the cell body. Overall, 4 repeat
tau has a more profound effect than 3 repeat tau on mitochondrial trafficking in primary
neuronal axons.
Discussion
Four-repeat isoforms are over-represented in autosomal dominantly inherited cases of
frontotemporal dementia, but the physiologically important consequence of 4 repeat tau (as
compared with 3 repeat tau) that leads to neurodegeneration remains uncertain (Mandelkow
et al. 2007; van Swieten and Spillantini 2007; Spires-Jones et al. 2009; Wolfe 2009). A major
alteration in 4 repeat to 3 repeat ratio has also been demonstrated in sporadic forms of other
neurodegenerative diseases, including corticobasal ganglionic degeneration, progressive
supranuclear palsy (Ingelsson et al. 2007) and, to a lesser extent, Alzheimer’s disease (Conrad
et al. 2007). Moreover, previous studies using a variety of non-neuronal or reduced preparations
have suggested that tau might have an effect on organelle transport by reducing the attachment
frequency of motors to microtubules but not altering velocities once attached (Trinczek et al.
1999; Seitz et al. 2002) or by differentially regulating kinesin and dynein based transport
(Vershinin et al. 2008). We therefore re-examined the effects of 3 repeat and 4 repeat tau on
mitochondrial transport in central nervous system cells, to evaluate (i) whether differential
effects of 3 repeat and 4 repeat tau could be uncovered and, (ii) whether the primary effect of
tau was via competition for kinesin/dynein-mediated transport or by impacting the properties
of microtubular transport after it had been initiated.
It is well established that tau strongly impacts mitochondrial translocation to and transport in
axons (Sato-Harada et al. 1996; Mandelkow et al. 2004). Tau over-expression leads to a clear
phenotype of clustering of mitochondria in the perinuclear area in multiple cell types, including
CHO cells and retinal ganglion cells (Ebneth et al. 1998; Stamer et al. 2002; Mandelkow et
al. 2004; Gotz et al. 2006; Dubey et al. 2008), suggesting an impact on transport of organelles
toward the cell periphery which has been attributed to competition for kinesin-based
anterograde transport between tau and other kinesin cargoes. Our studies show that, in both
H4 neuroglioma cells and in primary neurons, tau overexpression leads to a decrease in
mitochondrial transport to the periphery of the cell body. Although both 3 repeat and 4 repeat
tau have a strong effect on mitochondrial trafficking to axons, the 4 repeat-containing isoforms
have a markedly greater influence than the 3 repeat-containing isoforms.
Previous studies in cells suggested that full-length 4 repeat tau primarily changed the likelihood
that kinesin cargoes were transported, with little effect on velocities and transport
characteristics (Ebneth et al. 1998; Stamer et al. 2002; Mandelkow et al. 2003). By contrast,
elegant in vitro single molecule studies of motor proteins moving along microtubules (Dixit
et al. 2008) showed that kinesin tended to detach at patches of bound tau, whereas dynein
tended to reverse direction. In another set of studies, Vershinin et al. (2007, 2008) examined
the influence of tau on the kinesin and dynein motor proteins in their movement of cargo along
microtubules utilizing taxol-stabilized microtubules and an optical trap with motor proteins
bound to polystyrene beads as cargo (Vershinin et al. 2007, 2008). High levels of tau binding
to microtubules significantly decreased, or abolished kinesin binding to microtubules, while
the same tau concentrations had far less of an effect on dynein binding to microtubules. Tau-
binding microtubules also decreased the distance traveled by individual motor proteins along
microtubules, again with kinesin being affected to a far greater extent than dynein. In accord
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with our observations, 3 repeat tau had a more significant effect than 4 repeat tau on both
kinesin and dynein binding to and movement along stabilized microtubules (Vershinin et al.
2007, 2008). Our data do not distinguish between the possibility that velocity of organelle
transport is affected by tau, or that there is a difference in the rate at which organelles attach
and detach from microtubules so that periods of short movement could be averaged with
stationary periods. Regardless, it seems clear from our results as well as those of other studies
(Thies and Mandelkow 2007; Vershinin et al. 2007, 2008), that tau has multiple effects on
mitochondrial trafficking and localization within neurons.
Our studies, using microfluidic devices that allow monitoring of mitochondrial movement in
axons, support the idea that tau over-expression alters both the likelihood that mitochondria
are trafficked to axons and the properties of anterograde and retrograde movement. For
example, in strong agreement with Thies and Mandelkow (2007) and other reports, tau
profoundly impacts mitochondrial localization and leads to clustering in the cell body.
However, our studies also suggest that the velocity of anterograde transport is significantly
impacted by tau expression, contrasting in this regard with Thies and Mandelkow (2007). This
difference may be because of technical issues such as the use of hippocampal and cortical
neurons, use of the microfluidic devices, or use of a genetically encoded mitochondrial marker
compared with MitoTracker dyes (Thies and Mandelkow 2007). Interestingly, there appears
to be a net effect of diminishing the anterograde to retrograde ratio, leading to a lower level of
anterograde net flux. Thus, mitochondria may cluster in the cell soma for two reasons:
competition for kinesin-based transport that leads to diminished translocation to the axonal
microtubules (or, in H4 cells, the cell periphery), and a stronger effect on kinesin compared to
dynein-mediated transport mechanisms leading to a bias favoring retrograde transport for
mitochondria that reach the axon. Four-repeat tau may have a more profound influence on the
competition for kinesin-based mitochondrial transport, whereas our data suggest that 3 repeat
tau may impact movement within the axon to a greater extent. Our detailed kymograph analyses
of tau effects on mitochondrial trafficking in axons of living neurons match very well with
predictions from single molecule studies of dynein and kinesin motor proteins ex vivo (Dixit
et al. 2008), extending these observations to an in vitro trafficking of mitochondria.
Our current results are also in accord with recent studies of axonal transport in tau over-
expressing mice, where in some models there is a reduced synaptic supply of transported
cargoes, such as tyrosine hydroxylase delivery to the striatum in a model that over-expresses
K369Z mutant tau in the substantia nigra (Ittner et al. 2008).
The effects of tau on axonal transport in our current studies are independent of the formation
of fibrillar tau inclusions. The type of changes we observe in both axonal translocation and in
axonal transport due to tau over-expression may help explain the phenotype of rTg4510 mice,
in which tau P301L over-expression leads to tangle formation, neuronal loss, and cognitive
impairments (SantaCruz et al. 2005; Spires et al. 2006). In this model, suppressing tau over-
expression led to restoration of behavioral function despite the continued presence of
neurofibrillary tangles, arguing that the neural dysfunction was a consequence of soluble tau
expression rather than the presence of neurofibrillary lesions. If so, the current results suggest
that one consequence of overexpression of soluble tau (as opposed to fibrillar tau accumulation)
is likely to be defects in microtubule trafficking to axons and in anterograde and retrograde
axonal transport. Thus, tau-induced changes in axonal transport may be a major underlying
theme in neurodegenerative diseases associated with genetic or pathophysiologic alterations
that lead to changes in tau’s interaction with microtubules.
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Abbreviations used
CFP cyan fluorescent protein
CHO Chinese hamster ovary
DIV days in vitro
GFP green fluorescent protein
Mito-DsRed mitochondrial DsRed
NB neurobasal
PBS phosphate-buffered saline
RT room temperature
SDS sodium dodecyl sulfate
TBST 20 mM Tris–Cl pH 7.6, 137 mM NaCl, 0.05% Tween 20
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Fig. 1.
Constructs expressing five different isoforms of tau tagged with fluorescent proteins were
generated with relative mobilities shown in a denaturing western blot (a). Constructs differed
in the inclusion or exclusion of the splice changeable exons 2, 3 and 10 as well as one construct
cleaved at amino acid 421 (4R + 2 + 3C3 construct) mimicking caspase 3 cleavage of tau
(Gamblin et al. 2003). A schematic in (b) shows which exons are included in each construct.
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Fig. 2.
Mitochondrial distribution in H4 cells is altered by tau expression. Representative
photomicrographs (a) show H4 cells transfected with either GFP or GFP-Tau 4 repeat plus 2
plus 3 lacking the last 20 aa (Tau4RC3). Cells were co-transfected with GFP or GFP-Tau4RC3
(green) and Mito-DsRed (red) to label mitochondria demonstrating the clumping of
mitochondria around the nucleus in Tau-transfected cells. Quantification of mitochondrial
distribution (b) shows a significant reduction in the area of cell soma occupied by mitochondria
with overexpression of tau (# p < 0.0001 Mann–Whitney test tau vs. control). Four-repeat tau
isoforms had a significantly more pronounced effect on mitochondrial clumping (* Mann–
Whitney test 3 repeat vs. 4 repeat p < 0.0001). Within the 3 repeat and 4 repeat groups, addition
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of the N-terminal inserts or truncation at the caspase cleavage site (C3) did not have a further
effect on mitochondrial distribution. The data are non-parametric thus are presented as box
plots, which display the median value (line inside the box), upper quartile (top of the box),
lower quartile (bottom of the box), 90th percentile (top whisker), 10th percentile (bottom
whisker), and all values below the 10th and above the 90th percentile (potential outliers) shown
as dots. n = 45 cells per condition. Scale bar 20 μm.
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Fig. 3.
Microfluidic devices with a design adapted from Taylor et al. (2005) were used to plate primary
cortical neurons to isolate axons from cell bodies and dendrites [schematic shown in (a)]. (b)
A photomicrograph of a microfluidic device with cultured neurons expressing CFP shows
axons penetrating the microchannels. Scale bars 3 mm (a) 50 μm (b).
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Fig. 4.
Mitochondrial distribution in neurons plated on microfluidic devices is altered by expression
of human tau. In neuronal cell bodies (a), expression of tau significantly decreased the area of
the cell body occupied by mitochondria (# p < 0.0001, Mann–Whitney test control vs. tau).
Four-repeat isoforms had a more pronounced effect than 3 repeat isoforms (* p < 0.0001,
Mann–Whitney test 3 repeat vs. 4 repeat, tau group). Within the 4 repeat isoforms, the shortest
4 repeat construct, 4 repeat minus 2 minus 3, had less of an effect than the two longer isoforms
4 repeat plus 2 plus 3 and tau truncated at caspase cleavage site 421, 4 repeatC3 (+ p < 0.0001,
post hoc Mann–Whitney tests 4 repeat minus 2 minus 3 vs. 4 repeat plus 2 plus 3 and 4
repeatC3), n = 35 cells. In the axons (b), expression of tau similarly decreases the area occupied
by mitochondria, in the axon (#), and 4 repeat tau still has a more pronounced effect than 3
repeat tau (*). Within the 4 repeat isoforms, the 4 repeat tau construct truncated at caspase
cleavage site 421 has a more pronounced effect than the other 4 repeat isoforms (+ p < 0.02,
post hoc Mann–Whitney test 4 repeat C3 vs. 4 repeat plus 2 plus 3 or 4 repeat minus 2 minus
3). As in Fig. 2, the number of individual mitochondria was not quantified, only the amount
of cytoplasm occupied by mitochondria in either the cell body (a) or the axon (b). The same
cells were used in (a) and (b), first the axon was imaged, and followed back to cell body, which
was then imaged. n = 35 cells per condition.
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Fig. 5.
Tau over-expression increases the net movement of axonal mitochondria toward the neuronal
cell body. (a) Shows a kymograph generated from a time series of mitochondria moving along
an axon. Images were taken every 2 s and a total of 100 images were taken, for a total imaging
session of 200 s. (b) Quantification of mitochondrial movements from the kymographs shows
that velocity of mitochondria moving anterogradely is decreased (# p = 0.03, Mann-Whitney
test control vs. tau), and that this reduction is more pronounced with 3 repeat tau than 4 repeat
tau (* p < 0.0001 post hoc Mann–Whitney test). Average retrograde velocity (c) is not affected
by tau over-expression. The percentage of mitochondria moving away from the cell body (d)
is decreased with tau overexpression (# p < 0.0001 Mann-Whitney test). Conversely, the
percentage of mitochondria moving retrogradely is increased with tau over-expression (# p <
0.0001, Mann-Whitney test), with 3 repeat tau having a more pronounced effect (* p < 0.0001
post hoc Mann–Whitney test) and with isoforms lacking N-terminal exons 2 and 3 having more
of an effect than the other isoforms with the same number of repeats (+ p < 0.01 post hoc Mann–
Whitney tests 3 repeat minus 2 minus 3 vs. 3 repeat plus 2 plus 3; 4 repeat minus 2 minus 3
vs. 4 repeat plus 2 plus 3; and 4 repeat minus 2 minus 3 vs. 4 repeat C3), n = 35 mitochondria
from at least 10 individual neurons for each condition. The same kymographs were used to
generate the data for (b), (c), and (d).
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